NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
SG&A Expenses Over TimeContracting
Percentile Rank27
3Y CAGR-29.6%
5Y CAGR-18.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-29.6%/yr
vs +1.5%/yr prior
5Y CAGR
-18.2%/yr
Recent deceleration
Acceleration
-31.1pp
Decelerating
Percentile
P27
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.65B-72.5%
2025$6.00B+12.0%
2024$5.36B+13.2%
2023$4.73B-5.4%
2022$5.00B+11.0%
2021$4.51B-5.6%
2020$4.77B+6.9%
2019$4.47B+30.5%
2018$3.42B+26.8%
2017$2.70B-